Lorena Pinheiro Figueiredo, Thiago Cerqueira-Silva, Andréa Magalhães, Ednaldo Lima Lago, Marcus Miranda Lessa
Journal: The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2023;27(1):102720
PMID: 36463934
INTRODUCTION
The pathogenesis of cutaneous and mucosal leishmaniasis is associated with different immune responses. Vitamin D may modulate the immune system. Here we evaluate the association of vitamin D levels with the severity of the clinical forms of cutaneous and mucosal leishmaniasis.
METHODS
We conducted an observational study evaluating the association between vitamin D levels, disease severity and therapeutic response in patients with cutaneous and mucosal leishmaniasis. Additionally, we conducted a cross-sectional study to compare vitamin D levels in patients with leishmaniasis and healthy subjects. Hypovitaminosis D was defined as a serum level of 25 (OH) D < 30 ng/mL.
RESULTS
In patients with leishmaniasis, vitamin D serum levels were 38.5 ± 11.54 ng/mL, and 37.5 ± 10.43 ng/mL in healthy subjects The prevalence of hypovitaminosis D was 23.3% and 20.0%, respectively (p = 0.72). There was no correlation between vitamin D serum levels, disease severity, and healing time in the mucosal leishmaniasis group.
CONCLUSION
Vitamin D levels are not associated with neither susceptibility nor severity of tegumentary leishmaniasis.
Copyright © 2022 Sociedade Brasileira de Infectologia. All rights reserved.
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.